|
Market Closed -
Nasdaq
21:00:00 14/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 44.84 USD | +0.47% |
|
-9.12% | +101.44% |
| 09-03 | LB Pharmaceuticals Inc Announces Appointment of Joseph M. Miller to Chief Financial Officer, Effective September 2, 2026 | CI |
| 09-03 | LB Pharmaceuticals Names Joseph Miller CFO | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LBRX | Delayed | |
CBOE
| LBRX | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 49.48 | 49.48 | 49.34 |
| Spread/Res. | -9.38% | -9.38% | -9.12% |
| Spread/Supp. | +1.29% | +30.77% | +60.31% |
| Support | 44.27 | 34.29 | 27.97 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LBRX Stock
- Charts LB Pharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
